Glioma
📧 Sign up to get email alerts when something new happens for Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma [EARLY_Phase 1]
Early-phase clinical trial investigating hyperpolarized carbon-13 alpha-ketoglutarate imaging in IDH-mutant glioma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade Gliomas [NA]
A ClinicalTrials.gov study is investigating brain stimulation combined with behavioral therapy to increase the extent of surgical resection …
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Platelets Activation in Brain Neoplasms [NA]
A clinical trial investigating platelets activation in brain neoplasms, including glioma, is currently recruiting. The sponsor is Fondation …
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer Using Pathology Biopsies
Mayo Clinic is advancing desorption electrospray ionization mass spectrometry (DESI-MS) for intraoperative molecular diagnosis of brain canc…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma [NA]
A recruiting clinical trial at the University of Rochester is exploring telehealth visits to discuss advanced directives for patients newly …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors [Phase 1]
Phase 1 trial evaluating locoregional HER2-targeted CAR T-cell therapy for pediatric recurrent or refractory central nervous system tumors a…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: NeuroPathways Intervention for Brain Tumor Patients [NA]
A clinical trial sponsored by Massachusetts General Hospital investigating NeuroPathways Intervention for glioma/brain tumors is currently r…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
This clinical trial update describes an observational study by the EORTC to assess treatment patterns and outcomes for patients with primary…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma. [Phase 1]
Phase 1 trial update on an adenovirus-mediated suicide gene therapy combined with radiotherapy for progressive astrocytoma; the study is cur…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Accelerating Motor Recovery in Glioma Patients Using Postoperative nrTMS [NA]
A clinical trial update notes ongoing research evaluating postoperative navigated repetitive transcranial magnetic stimulation (nrTMS) to ac…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Study of GC101 TIL in Brain Glioma (Soochow2) [EARLY_Phase 1]
A Phase 1 study evaluating GC101 TIL for glioma is currently recruiting, sponsored by Shanghai Juncell Therapeutics.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma. [EARLY_Phase 1]
Biogenea Pharmaceuticals is conducting an early-phase Phase 1 clinical study to evaluate the safety and potential efficacy of the Tamavaq AI…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: 18F-Fluciclovine PET-MRI in High-grade Glioma [EARLY_Phase 1]
An early-phase trial evaluating 18F-Fluciclovine PET-MRI for imaging high-grade glioma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG [EARLY_Phase 1]
This is an early-phase (Phase 1) clinical trial evaluating 18F-Fluciclovine PET-MRI imaging in low-grade glioma, currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Prospective Real-World Study of Pathology AI for Glioma Molecular Prediction
A prospective real-world study is evaluating AI-powered pathology for predicting molecular features of glioma; the trial is currently recrui…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Using the Epitranscriptome to Diagnose and Treat Gliomas [NA]
A clinical trial exploring epitranscriptome-based approaches to diagnose and treat gliomas is described; the study is currently not yet recr…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion [NA]
This clinical trial update describes a study using magnetic resonance elastography to investigate glioma tumor stiffness and adhesion. The t…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers. [Phase 2, Phase 3]
This clinical trial update describes Arm 03 of the DETERMINE trial evaluating entrectinib in adults, pediatric, and teenage/young adult pati…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations [Phase 2, Phase 3]
An ongoing DETERMINE trial (arm 06) investigates capmatinib for MET-dysregulated cancers, with Phase 2/3 testing and current recruitment.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas [NA]
This clinical trial update reports on the safety and feasibility of preoperative and intraoperative image-guided resection of gliomas, spons…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma [EARLY_Phase 1]
An early Phase 1 clinical trial evaluating simultaneous multinuclear metabolic MRI in patients with glioma, including newly diagnosed and re…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas
This clinical trial update describes the development of a new metabolic imaging approach (aMRI) to evaluate neurological disease in patients…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: A Study of 177Lu-PSMA-617 in People With Gliomas [Phase 1]
A Phase 1 clinical trial is evaluating 177Lu-PSMA-617 in patients with gliomas and related subtypes and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: Residual IDH1-Mutant Tumor Cell Quantification Study [NA]
Clinical trial update for a study on quantifying residual IDH1-mutant tumor cells in glioma, sponsored by NYU Langone Health, currently not …
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors [NA]
ClinicalTrials.gov entry describing a Memorial Sloan Kettering Cancer Center study that uses MRI to identify high-risk areas in gliomas to g…